✦ LIBER ✦

AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis

✍ Scribed by Kathline Kim; Dan H. Moore; Alexandros Makriyannis; Mary E. Abood

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The CB2 cannabinoid agonist AM-1241 prol

✍ Jennifer L. Shoemaker; Kathryn A. Seely; Ronald L. Reed; John P. Crow; Paul L. P 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 675 KB

Minocycline Slows Disease Progression in

✍ Jasna Kriz; Minh Dang Nguyen; Jean-Pierre Julien 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 435 KB

Ammonium tetrathiomolybdate delays onset

✍ Eiichi Tokuda; Shin-ichi Ono; Kumiko Ishige; Shunsuke Watanabe; Eriko Okawa; Yos 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 672 KB

The AMPA receptor antagonist NBQX prolon

✍ Philip Van Damme; Maarten Leyssen; Geert Callewaert; Wim Robberecht; Ludo Van De 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 173 KB

The Copper Chelator d-Penicillamine Dela

✍ Andreas F. Hottinger; Eric G. Fine; Mark E. Gurney; Anne D. Zurn; Patrick Aebisc 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 373 KB

Selective Loss of α Motoneurons Innervat

✍ M.Hasan Mohajeri; Denise A. Figlewicz; Martha C. Bohn 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 152 KB